On (b)(6) 2015, dako received a complaint regarding the routine use of the flex monoclonal mouse anti-human wilms' tumor 1 (wt1) protein clone 6f-h2 on the autostainer link 48 for diagnostic use.Initially the customer reported false positive staining, claiming that this staining contributed to a diagnostic error leading to distress, unnecessary surgery and other incorrect treatment.On august 12, 2015, dako received follow up information regarding this incident.The customer reported that they have revalidated the same batch of wt1 used in the original testing and have confirmed expected staining results.The customer reported that a retest was also carried out at another laboratory, on sections from the same biopsy, and results were also positive.The customer reported that a separate test can on surgical test resection tissue done at another hospital was negative.The customer reported that as a result of these conclusions, the customer has informed dako that they are no longer pursuing a complaint about dako regarding false positive staining with the wt1 antibody.Dako is in the process of obtaining details of this complaint for further investigation.
|
Follow-up: after further investigation, dako has discovered that the problem complaint described in this mdr, 2022180-2015-0002, had nothing to do with the wt1 antibody.The issue was discovered to be related to the envision flex+ product problem that was outlined in mdr 9610099-2015-2015.This investigation is closed.
|